Cash & equivalents decreased 87.2%
Cash & equivalents changed -87.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -87.2% from the comparable as-filed period.
Gross margin changed -2133 basis points from the comparable as-filed period.
Gross profit changed -226.6% from the comparable as-filed period.
Inventory changed +159.1% from the comparable as-filed period.
Operating cash flow changed -38.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating margin changed +1743 basis points from the comparable as-filed period.
Research & development changed -49.4% from the comparable as-filed period.
Revenue changed +44.3% from the comparable as-filed period.
Stock-based compensation changed -43.8% from the comparable as-filed period.
Net income changed -10.1% from the comparable as-filed period.
Operating income changed -10.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.